4.5 Editorial Material

Retained placenta: will medical treatment ever be possible?

Journal

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
Volume 95, Issue 5, Pages 501-504

Publisher

WILEY
DOI: 10.1111/aogs.12848

Keywords

Retained placenta; medical treatment; way through medical treatment; delivery; postpartum hemorrhage

Funding

  1. National Institute for Health Research [II-LA-0712-20007] Funding Source: researchfish
  2. Department of Health [II-LA-0715-20008, II-LA-0712-20007] Funding Source: Medline
  3. National Institutes of Health Research (NIHR) [II-LA-0712-20007] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

The standard treatment for retained placenta is manual removal whatever its subtype (adherens, trapped or partial accreta). Although medical treatment should reduce the risk of anesthetic and surgical complications, they have not been found to be effective. This may be due to the contrasting uterotonic needs of the different underlying pathologies. In placenta adherens, oxytocics have been used to contract the retro-placental myometrium. However, if injected locally through the umbilical vein, they bypass the myometrium and perfuse directly into the venous system. Intravenous injection is an alternative but exacerbates a trapped placenta. Conversely, for trapped placentas, a relaxant could help by resolving cervical constriction, but would worsen the situation for placenta adherens. This confusion over medical treatment will continue unless we can find a way to diagnose the underlying pathology. This will allow us to stop treating the retained placenta as a single entity and to deliver targeted treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available